VEGFD and cancer: Because of this, although the statistical analysis showed no group differences in the mortality or safety outcomes, e.g., the incidence of cancer, it is important to be aware that this might had been simply because the groups were different in their size and the overall study population was relatively small (VEGF-D n = 24; control n = 6).